PL1638416T3 - Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej - Google Patents

Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Info

Publication number
PL1638416T3
PL1638416T3 PL04763015T PL04763015T PL1638416T3 PL 1638416 T3 PL1638416 T3 PL 1638416T3 PL 04763015 T PL04763015 T PL 04763015T PL 04763015 T PL04763015 T PL 04763015T PL 1638416 T3 PL1638416 T3 PL 1638416T3
Authority
PL
Poland
Prior art keywords
barrier function
nutritional formula
gut barrier
optimal gut
optimal
Prior art date
Application number
PL04763015T
Other languages
English (en)
Inventor
Clara Lucia Garcia-Rodenas
Gabriela Bergonzelli
Florence Rochat
Marco Enrico Turini
Irene Corthesy-Theulaz
Christine Cherbut
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL1638416T3 publication Critical patent/PL1638416T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733Fructosans, e.g. inulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/165Paracasei
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/533Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
PL04763015T 2003-06-23 2004-06-22 Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej PL1638416T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03014040 2003-06-23
PCT/EP2004/006736 WO2004112509A2 (en) 2003-06-23 2004-06-22 Nutritional formula for optimal gut barrier function
EP04763015.7A EP1638416B1 (en) 2003-06-23 2004-06-22 Use of a nutritional formula for optimal gut barrier function

Publications (1)

Publication Number Publication Date
PL1638416T3 true PL1638416T3 (pl) 2013-09-30

Family

ID=33522258

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04763015T PL1638416T3 (pl) 2003-06-23 2004-06-22 Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej

Country Status (10)

Country Link
US (1) US8394370B2 (pl)
EP (1) EP1638416B1 (pl)
CN (1) CN1863463B (pl)
AR (1) AR044888A1 (pl)
CA (1) CA2530437C (pl)
ES (1) ES2416287T3 (pl)
PL (1) PL1638416T3 (pl)
PT (1) PT1638416E (pl)
TW (1) TWI342779B (pl)
WO (1) WO2004112509A2 (pl)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
MXPA06015071A (es) * 2004-06-22 2007-08-06 Nutricia Nv Mejoramiento de la integridad de barrera con acidos grasos en pacientes con vih.
MXPA06015184A (es) 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
ATE434389T1 (de) 2004-11-18 2009-07-15 Nutricia Nv Verdickungsmittelzusammensetzung für dysphagia- patienten
CA2604338A1 (en) * 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
WO2006115412A2 (en) 2005-04-27 2006-11-02 N.V. Nutricia Nutrition with lipids and non-digestible saccharides
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
MX2007013028A (es) * 2005-06-06 2008-01-11 Bristol Myers Squibb Co Formulas infantiles con bajo contenido de fitato.
NO323665B1 (no) * 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
DE602006016444D1 (de) * 2005-07-01 2010-10-07 Nutricia Nv Babynahrung mit hydrolisierten proteinen
BRPI0616323A2 (pt) 2005-09-20 2011-06-14 Prolacta Bioscience Inc mÉtodo para determinar se um fluido mamÁrio doado foi obtido a partir de um indivÍduo especÍfico
WO2007039596A1 (en) * 2005-10-05 2007-04-12 Nestec S.A. Nutritional formulation for promoting catch-up growth
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
AU2015218488B2 (en) * 2005-10-21 2017-02-02 N.V. Nutricia Method for stimulating the intestinal flora
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
MY148872A (en) * 2006-02-15 2013-06-14 Nestec Sa Use of bifidobacterium longum for the prevention and treatment of inflammation
PL1993577T3 (pl) * 2006-03-10 2014-07-31 Nutricia Nv Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach
WO2007121273A2 (en) * 2006-04-11 2007-10-25 Martek Biosciences Corporation Food products comprising long chain polyunsaturated fatty acids and methods for preparing the same
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
ES2633922T3 (es) * 2006-11-29 2017-09-26 Prolacta Bioscience, Inc. Composiciones de leche humana y métodos para la preparación y uso de las mismas
CA2706723C (en) 2006-12-08 2015-05-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
ES2668552T3 (es) * 2007-03-21 2018-05-18 Nestec S.A. Sistema de seguridad para composiciones nutricionales en polvo
JP2009102292A (ja) * 2007-04-27 2009-05-14 Chiba Prefecture ストレス抑制剤
DK1992351T3 (en) * 2007-05-18 2016-06-06 Nestec Sa Lactobacillus johnsonii for the prevention of post-surgical infection
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
PT2217246E (pt) * 2007-11-08 2015-02-10 Nestec Sa Utilização de oligossacáridos contendo n-acetil-lactosamina para maturação de respostas imunes em recém-nascidos
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009097040A1 (en) * 2008-01-28 2009-08-06 Mead Johnson Nutrition Company Nutritional composition containing dha, rumenic acid, and gangliosides
NL2001377C2 (nl) * 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
US9439885B2 (en) * 2008-06-03 2016-09-13 Mead Johnson Nutrition Company Method for inhibiting the growth of bacteria
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
DK2285387T3 (en) * 2008-06-13 2016-01-25 Nutricia Nv Nutrition for preventing infections
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
MX354119B (es) * 2008-11-21 2018-02-14 Antonio Cruz Serrano Jose Una mezcla para preparar un alimento funcional con acción simbiótica sinérgica que comprede: por lo menos una cepa probiótica, un solución prebiótica y nutrientes para consumo humano y un método para obtener la misma.
ES2527959T3 (es) 2008-12-02 2015-02-02 Prolacta Bioscience, Inc. Composiciones de permeado de leche humana y métodos para realizarlas y usarlas
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
EP2418969B1 (en) * 2009-04-15 2013-03-06 N.V. Nutricia Anti-reflux infant nutrition
CA2761444C (en) * 2009-05-11 2018-04-24 Nestec S.A. Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
RU2563355C2 (ru) * 2009-12-08 2015-09-20 Нестек С.А. Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
KR101411679B1 (ko) 2010-04-26 2014-06-25 엔지모테크 리미티드 장내 세균총 생육 촉진 방법 및 지질 조성물
WO2011136636A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
EP2563165A1 (en) * 2010-04-27 2013-03-06 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
WO2011148221A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Lactic acid bacteria for maturation of the enteric nervous system in infants
CN103415297A (zh) * 2010-12-29 2013-11-27 雀巢产品技术援助有限公司 用于减少压力相关肠症状的包含纤维和益生菌的营养组合物
CN103763940B (zh) * 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
WO2012092156A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
SG10201707519PA (en) * 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
BR112013015951A2 (pt) 2010-12-31 2018-07-10 Abbott Lab composições nutricionais compreendendo oligossacarídeos e nucleotídeos de leite humano e usos destas para tratar e/ou prevenir infecção viral entérica.
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
EP2658546B1 (en) 2010-12-31 2018-12-05 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
NZ612105A (en) 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides for modulating inflammation
BR112013020108A2 (pt) 2011-02-10 2017-06-13 Nestec Sa modulação do crescimento de bifidobactérias usando uma combinação de oligossacarídeos encontrados no leite de ser humano
JP2014506923A (ja) * 2011-03-01 2014-03-20 クオラム イノベーションズ リミテッド ライアビリティ カンパニー 病原性バイオフィルムと関連した状態を治療するための物質および方法
BR112013026082A2 (pt) * 2011-04-12 2019-09-24 Nestec Sa composições nutricionais incluindo ácidos graxos de cadeia ramificada para melhorar função de barreira intestinal
CN103997899B (zh) 2011-06-20 2016-04-20 H.J.亨氏公司 益生菌组合物和方法
BR112014000322A2 (pt) * 2011-07-12 2017-01-10 Nestec Sa "probióticos, e seus usos"
ES2657744T3 (es) * 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
PT2739157T (pt) 2011-08-03 2018-01-09 Prolacta Bioscience Inc Microfiltração de leite humano para reduzir a contaminação bacteriana
US10639319B2 (en) * 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PT2775852T (pt) * 2011-10-18 2016-11-08 Nestec Sa Composição para utilização no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
US20140286908A1 (en) * 2011-10-18 2014-09-25 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
WO2013126015A1 (en) * 2012-02-23 2013-08-29 N. V. Nutricia Composition comprising non- digestible oligosaccharides
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
US20140037813A1 (en) * 2012-08-02 2014-02-06 Mead Johnson Nutrition Company Nutritional creamer composition
WO2014092564A1 (en) * 2012-12-10 2014-06-19 N.V. Nutricia Nutritional composition with non digestible oligosaccharides
MX2015007933A (es) * 2012-12-18 2015-10-09 Abbott Lab Oligosacaridos de leche humana para mejorar sintomas de estres.
US20140251944A1 (en) * 2013-03-08 2014-09-11 Nelson Jesus Spinetti Happy baby bottle
PT2967094T (pt) 2013-03-13 2021-01-14 Prolacta Bioscience Inc Produtos de leite humano com elevado teor de matéria gorda
WO2015077233A1 (en) 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
WO2015085549A1 (en) 2013-12-12 2015-06-18 Nestec S.A. An age-tailored nutrition system for an infant
CN104041906A (zh) * 2014-06-27 2014-09-17 施文康 一种断奶饮料的制作方法
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
WO2017117409A1 (en) 2015-12-30 2017-07-06 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
US20180103675A1 (en) * 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
CN108813262A (zh) * 2018-07-02 2018-11-16 杭州相生相成科技有限公司 一种含dha藻油的复合益生菌固体饮料
DE202019005475U1 (de) * 2018-12-21 2020-09-23 Société des Produits Nestlé S.A. Eine Nahrungsmittelzusammensetzung umfassend 2'-Fucosyllactose zur Verbesserung der gastrointestinalen Barriere
IT201900000043A1 (it) * 2019-01-03 2020-07-03 Watt S R L Sostituto della prima colazione
WO2020156679A1 (en) * 2019-02-01 2020-08-06 Adisseo France S.A.S. Use of a thraustochytrid biomass for maintaining gut barrier function
EP3968787A1 (en) 2019-05-15 2022-03-23 N.V. Nutricia Fermented formula for improving intestinal development
PT3883393T (pt) * 2019-06-04 2022-12-07 Nutricia Nv Composição nutricional compreendendo 2'fucosilactose e butirato dietético
US20220110985A1 (en) 2019-06-04 2022-04-14 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
CN110742275A (zh) * 2019-09-30 2020-02-04 北京斯利安药业有限公司 一种dha蛋黄粉及其制备方法与应用
CN116103160A (zh) * 2022-10-20 2023-05-12 生物源生物技术(深圳)股份有限公司 一种食用菌菌丝体发酵液的制备方法、发酵液及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
JPH0530942A (ja) * 1991-07-25 1993-02-09 Riyoushiyoku Kenkyukai 高分子の腸管透過性を制御する効果のある 飲食品及び医薬品
ES2110986T3 (es) 1991-08-12 1998-03-01 Nestle Sa Composicion alimenticia.
JP3002850B2 (ja) 1992-03-31 2000-01-24 雪印乳業株式会社 ガングリオシドgm3配合栄養組成物
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6132710A (en) 1997-03-17 2000-10-17 Probiotix, Inc. Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
DE69802413T3 (de) * 1997-07-05 2009-07-16 Société des Produits Nestlé S.A. LACTOBACILLI ZUR ERHöHUNG DER MINERALIENABSORPTION DURCH DARMZELLEN
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
EA200100662A1 (ru) 1998-12-15 2001-12-24 Американ Хоум Продактс Корпорейшн Способ и композиция для поддержания и восстановления целостности кишки
JP3411965B2 (ja) 1999-06-30 2003-06-03 雪印乳業株式会社 ポリアミン含有組成物の製造方法
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
WO2001064225A1 (en) * 2000-03-01 2001-09-07 Societe Des Produits Nestle S.A. Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
US20020044988A1 (en) 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
JP3853673B2 (ja) 2001-03-09 2006-12-06 森永乳業株式会社 C型慢性肝炎治療剤
EP1281325A1 (en) 2001-07-30 2003-02-05 Societe Des Produits Nestle S.A. Nutritional composition preventing bacterial overgrowth
EP1446023B1 (en) * 2001-11-12 2009-02-25 Mars, Incorporated Foodstuff for cats and dogs

Also Published As

Publication number Publication date
US20070104700A1 (en) 2007-05-10
WO2004112509A2 (en) 2004-12-29
ES2416287T3 (es) 2013-07-31
CN1863463A (zh) 2006-11-15
TW200507863A (en) 2005-03-01
CN1863463B (zh) 2011-05-04
CA2530437C (en) 2011-11-15
TWI342779B (en) 2011-06-01
PT1638416E (pt) 2013-07-08
US8394370B2 (en) 2013-03-12
EP1638416A2 (en) 2006-03-29
EP1638416B1 (en) 2013-05-01
AR044888A1 (es) 2005-10-05
CA2530437A1 (en) 2004-12-29
WO2004112509A3 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
PL1638416T3 (pl) Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
HK1139681A1 (en) Salts of valsartan
EP1699760A4 (en) ANTI-HYPERCHOLESTEROLEMIA COMPOUNDS
GB0324886D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
GB0305927D0 (en) Compound
HK1094190A1 (en) a polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
GB0306718D0 (en) Compound
AP2005003329A0 (en) Chemically acidified formula
GB0328490D0 (en) Medicinal compounds
GB0317841D0 (en) Compound
GB0310361D0 (en) Pharmaceutical compound
GB0309120D0 (en) A set of parts
EG23601A (en) A group of scessors for opening sermony
AU152187S (en) A trocar
GB0323215D0 (en) A spirometer
AU151658S (en) A wall plaque
AU151652S (en) A wall plaque
AU151656S (en) A wall plaque
AU151654S (en) A wall plaque
AU151661S (en) A wall plaque
AU151659S (en) A wall plaque
AU151653S (en) A wall plaque
AU151655S (en) A wall plaque
AU151651S (en) A wall plaque